The fundamental role of epigenetic events in cancer - PubMed (original) (raw)
Review
doi: 10.1038/nrg816.
Affiliations
- PMID: 12042769
- DOI: 10.1038/nrg816
Review
The fundamental role of epigenetic events in cancer
Peter A Jones et al. Nat Rev Genet. 2002 Jun.
Abstract
Patterns of DNA methylation and chromatin structure are profoundly altered in neoplasia and include genome-wide losses of, and regional gains in, DNA methylation. The recent explosion in our knowledge of how chromatin organization modulates gene transcription has further highlighted the importance of epigenetic mechanisms in the initiation and progression of human cancer. These epigenetic changes -- in particular, aberrant promoter hypermethylation that is associated with inappropriate gene silencing -- affect virtually every step in tumour progression. In this review, we discuss these epigenetic events and the molecular alterations that might cause them and/or underlie altered gene expression in cancer.
Similar articles
- Epigenetic gene silencing in acute promyelocytic leukemia.
Villa R, De Santis F, Gutierrez A, Minucci S, Pelicci PG, Di Croce L. Villa R, et al. Biochem Pharmacol. 2004 Sep 15;68(6):1247-54. doi: 10.1016/j.bcp.2004.05.041. Biochem Pharmacol. 2004. PMID: 15313423 Review. - The fundamental role of epigenetics in hematopoietic malignancies.
Galm O, Herman JG, Baylin SB. Galm O, et al. Blood Rev. 2006 Jan;20(1):1-13. doi: 10.1016/j.blre.2005.01.006. Epub 2005 Feb 23. Blood Rev. 2006. PMID: 16426940 Review. - DNA hypermethylation: when tumour suppressor genes go silent.
Garinis GA, Patrinos GP, Spanakis NE, Menounos PG. Garinis GA, et al. Hum Genet. 2002 Aug;111(2):115-27. doi: 10.1007/s00439-002-0783-6. Epub 2002 Jul 16. Hum Genet. 2002. PMID: 12189484 Review. - Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T, Sawan C, Herceg Z. Vaissière T, et al. Mutat Res. 2008 Jul-Aug;659(1-2):40-8. doi: 10.1016/j.mrrev.2008.02.004. Epub 2008 Feb 29. Mutat Res. 2008. PMID: 18407786 Review. - Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
Baylin SB, Ohm JE. Baylin SB, et al. Nat Rev Cancer. 2006 Feb;6(2):107-16. doi: 10.1038/nrc1799. Nat Rev Cancer. 2006. PMID: 16491070 Review.
Cited by
- USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21.
Liu Y, Yuan M, Xu X, Yang H, Yao Y, Hou P, Yu W, Ji M. Liu Y, et al. Int J Biol Sci. 2024 Sep 23;20(13):5223-5238. doi: 10.7150/ijbs.99817. eCollection 2024. Int J Biol Sci. 2024. PMID: 39430240 Free PMC article. - Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in _H. pylori-_CagA transfected gastric cancer cells.
Chen D, Li C, Zhao Y, Zhou J, Wang Q, Xie Y. Chen D, et al. PeerJ. 2021 Apr 15;9:e11203. doi: 10.7717/peerj.11203. eCollection 2021. PeerJ. 2021. PMID: 33954041 Free PMC article. - Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes.
Xie CR, Sun H, Wang FQ, Li Z, Yin YR, Fang QL, Sun Y, Zhao WX, Zhang S, Zhao WX, Wang XM, Yin ZY. Xie CR, et al. Mol Med Rep. 2015 Sep;12(3):4250-4258. doi: 10.3892/mmr.2015.3974. Epub 2015 Jun 22. Mol Med Rep. 2015. PMID: 26099202 Free PMC article. - Cancer epigenetics: new therapies and new challenges.
Hatzimichael E, Crook T. Hatzimichael E, et al. J Drug Deliv. 2013;2013:529312. doi: 10.1155/2013/529312. Epub 2013 Feb 26. J Drug Deliv. 2013. PMID: 23533770 Free PMC article. - Promoter hypermethylation and downregulation of the FAS gene may be involved in colorectal carcinogenesis.
Manoochehri M, Borhani N, Karbasi A, Koochaki A, Kazemi B. Manoochehri M, et al. Oncol Lett. 2016 Jul;12(1):285-290. doi: 10.3892/ol.2016.4578. Epub 2016 May 16. Oncol Lett. 2016. PMID: 27347139 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources